OQROGet OQRO Pro
Insider trade

Quest Diagnostics (DGX)Officer sold ~$874K

Karthik Kuppusamy, Officer at Quest Diagnostics, sold ~$874K of Quest Diagnostics shares.

~$874K
Approx. value · 5,224 sh @ $167.40
11K
Holds after · shares reported
Traded
Jul 30, 2025
Filed
Aug 1, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jul 24, 2025FDAFDA device approval: Quest Diagnostics AAVrh74 Antibody ELISA CDx
  2. Jul 30, 2025 · this disclosureInsiderOfficer sold ~$874K of DGX shares in the open market

What came next

  1. Jul 30, 2025InsiderOfficer sold ~$510K of DGX shares in the open market
  2. Jul 31, 2025InsiderOfficer sold ~$376K of DGX shares in the open market
  3. Aug 6, 2025Insider · 1 personInsiders: 2 sales (~$969K)
  4. Aug 15, 2025InsiderOfficer sold ~$356K of DGX shares in the open market
  5. Aug 19, 2025InsiderOfficer sold ~$829K of DGX shares in the open market
  6. Aug 21, 2025InsiderOfficer sold ~$365K of DGX shares in the open market
  7. Sep 23, 2025InsiderOfficer sold ~$5.29M of DGX shares in the open market
  8. Sep 24, 2025InsiderOfficer sold ~$33K of DGX shares in the open market
  9. Sep 26, 2025Insider · 1 personInsiders: 2 sales (~$43K)
  10. Oct 21, 2025Company filing · Form 8-K · ResultsReported its results
  11. Oct 22, 2025InsiderDirector sold ~$270K of DGX shares in the open market
  12. Nov 18, 2025Insider · Their largest sale since 2024Officer sold ~$1.49M of DGX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Quest Diagnostics

For Quest Diagnostics, OQRO holds 5 insider filings (SEC Form 4 or Form 144), 5 Congress trade reports, 12 fund holdings reports (13F) and 7 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DGX page.

Other recent filings by Karthik Kuppusamy, SVP, Clinical Solutions

The full history of Karthik Kuppusamy, SVP, Clinical Solutions is on the profile page.

How this filing works

Other disclosures at Quest Diagnostics

Everything OQRO holds on this company is on its DGX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data